Short Answer
Suppose you are studying tumor heterogeneity in a certain type of melanoma. You have used fluorescence-activated cell sorting (FACS) to specifically isolate those melanoma tumor cells that either do (first category) or do not (second category) express a specific marker present in normal stem cells in the tissue of origin (i.e. the melanocyte stem cells). You implant the same number of cells from each of these categories into severely immunodeficient mice and compare the tumor-formation efficiencies after several weeks, which turn out to be significantly higher for the first category. You then analyze the new tumors using FACS, and find out that the majority of the cells in the tumors that originated from the first category of cells harbor the stem-cell marker, whereas the majority of the cells in the tumors that originated from the second cell category lack the marker, just like their respective founder cells. Do these observations support the existence of cancer stem cells? Write down Yes or No as your answer.
Correct Answer:

Verified
Cancer stem cells are expected to const...View Answer
Unlock this answer now
Get Access to more Verified Answers free of charge
Correct Answer:
Verified
View Answer
Unlock this answer now
Get Access to more Verified Answers free of charge
Q27: In medical oncology, PET (positron emission tomography)
Q28: Which of the following proteins is NOT
Q29: The Rb gene in retinoblastomas is similar
Q30: The genotypes of 400 colorectal cancer tumors
Q31: Genetically knocking out both copies of the
Q33: You have analyzed a large set of
Q34: Compared to cells of a normal tissue,
Q35: You have karyotyped cells from two colorectal
Q36: Mutations in two important cancer-critical genes, encoding
Q37: Retinoblastoma is an early-onset cancer of the